![](https://partners4access.com/wp-content/uploads/2022/09/NICElinkedinV4-300x178.png)
Blogs
Is the Innovative Medicines Fund a risk too great for small pharmaceutical companies?
By Fisentzos Stylianou, PhD Contact: [email protected] NICE’s launches a real-world evidence framework Closing knowledge gaps and advancing patient access to innovations are major aims of the